{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:13:30Z","timestamp":1788506010548,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-026-01558-5","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:35:28Z","timestamp":1788503728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Playing by the Rules: A Review of the Modern Regulatory Framework for Regenerative Medicine"],"prefix":"10.1007","volume":"30","author":[{"given":"Alexander Schnabel","family":"Rothkrug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"1558_CR1","unstructured":"Shapiro JK, Wesoloski BJ. FDA\u2019s regulatory scheme for human tissue. In: Hyman, Phelps & McNamara, PC. 2007. Available from: https:\/\/hpm.com\/wp-content\/uploads\/2007\/12\/00396737-1.pdf"},{"issue":"8","key":"1558_CR2","first-page":"15","volume":"7","author":"AW Willcox","year":"1944","unstructured":"Willcox AW, The Public Health Service Act., 1944. Soc Secur Bull. 1944;7(8):15\u201317. Available from: https:\/\/www.ssa.gov\/policy\/docs\/ssb\/v7n8\/v7n8p15.pdf","journal-title":"Soc Secur Bull"},{"key":"1558_CR3","unstructured":"LII \/ Legal Information Institute. 42 U.S. Code \u00a7 264 - Regulations to control communicable diseases. Available from: https:\/\/www.law.cornell.edu\/uscode\/text\/42\/264"},{"key":"1558_CR4","unstructured":"FDA Regulation of human cells and tissues. Available from: https:\/\/www.fda.gov\/media\/133837\/download"},{"key":"1558_CR5","unstructured":"Commissioner O of the. Location of FDA and its Predecessors in Federal Government. FDA. 2021 Mar 26. Available from: https:\/\/www.fda.gov\/about-fda\/changes-science-law-and-regulatory-authorities\/location-fda-and-its-predecessors-federal-government"},{"issue":"7","key":"1558_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/term.2683","volume":"12","author":"K Yano","year":"2018","unstructured":"Yano K, Speidel AT, Yamato M. Four Food and Drug Administration draft guidance documents and the REGROW Act: A litmus test for future changes in human cell- and tissue\u2010based products regulatory policy in the United States? J Tissue Eng Regen Med. 2018;12(7):1579\u201393. https:\/\/doi.org\/10.1002\/term.2683.","journal-title":"J Tissue Eng Regen Med"},{"key":"1558_CR7","unstructured":"Federal Register. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. 2004. Available from: https:\/\/www.federalregister.gov\/documents\/2004\/11\/24\/04-25798\/current-good-tissue-practice-for-human-cell-tissue-and-cellular-and-tissue-based-product"},{"key":"1558_CR8","unstructured":"Federal Register. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. 2001. Available from: https:\/\/www.federalregister.gov\/documents\/2001\/01\/19\/01-1126\/human-cells-tissues-and-cellular-and-tissue-based-products-establishment-registration-and-listing"},{"key":"1558_CR9","unstructured":"Federal Register. Revocation of the regulations for human tissue intended for transplantation and human dura mater. 2022. Available from: https:\/\/www.federalregister.gov\/documents\/2022\/01\/13\/2022-00492\/revocation-of-the-regulations-for-human-tissue-intended-for-transplantation-and-human-dura-mater"},{"key":"1558_CR10","unstructured":"United States v. U.S, Stem Cell Clinic. LLC, 998 F.3d 130211th Cir. (2021)."},{"key":"1558_CR11","unstructured":"Justia Law. USA V, California stem cell treatment center INC. No. 22-560149th Cir. (2024). Available from: https:\/\/law.justia.com\/cases\/federal\/appellate-courts\/ca9\/22-56014\/22-56014-2024-09-27.html"},{"key":"1558_CR12","unstructured":"Center for biologics evaluation and research. Framework for the regulation of regenerative medicine products. FDA. 2020 Oct 20. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/framework-regulation-regenerative-medicine-products"},{"key":"1558_CR13","unstructured":"Center for biologics evaluation and research. regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use. FDA. 2020. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal"},{"key":"1558_CR14","unstructured":"Center for biologics evaluation and research. expedited programs for regenerative medicine therapies for serious conditions. FDA. 2019. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/expedited-programs-regenerative-medicine-therapies-serious-conditions"},{"key":"1558_CR15","unstructured":"Center for biologics evaluation and research. evaluation of devices used with regenerative medicine advanced therapies. FDA. 2019. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/evaluation-devices-used-regenerative-medicine-advanced-therapies"},{"key":"1558_CR16","unstructured":"Administration USF. and D. Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA\u2019s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health. Available from: https:\/\/www.prnewswire.com\/news-releases\/statement-from-fda-commissioner-scott-gottlieb-md-on-fdas-comprehensive-new-policy-approach-to-facilitating-the-development-of-innovative-regenerative-medicine-products-to-improve-human-health-300557743.html"},{"key":"1558_CR17","unstructured":"Center for biologics evaluation and research. Questions and answers regarding the end of the compliance and enforcement policy for certain human cells, tissues, or cellular or tissue-based products (HCT\/Ps). FDA. 2024 Apr 16. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/questions-and-answers-regarding-end-compliance-and-enforcement-policy-certain-human-cells-tissues-or"},{"issue":"11","key":"1558_CR18","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.stem.2021.10.008","volume":"28","author":"L Turner","year":"2021","unstructured":"Turner L. The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions. Cell Stem Cell. 2021;28(11):1891\u20135. https:\/\/doi.org\/10.1016\/j.stem.2021.10.008.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"1558_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2016.06.007","volume":"19","author":"L Turner","year":"2016","unstructured":"Turner L, Knoepfler P. Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry. Cell Stem Cell. 2016;19(2):154\u20137. https:\/\/doi.org\/10.1016\/j.stem.2016.06.007.","journal-title":"Cell Stem Cell"},{"key":"1558_CR20","unstructured":"US Stem Cell Clinic, LLC\u2009\u2013\u2009524470\u201308\/24\/2017. FDA. 2026. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/us-stem-cell-clinic-llc-524470-08242017"},{"key":"1558_CR21","doi-asserted-by":"publisher","first-page":"k2162","DOI":"10.1136\/bmj.k2162","volume":"361","author":"O Dyer","year":"2018","unstructured":"Dyer O. FDA seeks injunction against two stem cell clinics in first move against unregulated industry. BMJ. 2018;361:k2162. https:\/\/doi.org\/10.1136\/bmj.k2162.","journal-title":"BMJ"},{"key":"1558_CR22","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Evolutionary Biologics Inc. \u2013\u2009681586\u201312\/30\/2024. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/evolutionary-biologics-inc-681586-12302024"},{"key":"1558_CR23","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Skye Biologics Holdings LLC\u2009\u2013\u2009654466\u201312\/16\/2024. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/skye-biologics-holdings-llc-654466-12162024"},{"key":"1558_CR24","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. BioStem Life Sciences\u2009\u2013\u2009673788\u201301\/17\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/biostem-life-sciences-673788-01172025"},{"key":"1558_CR25","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Chara Biologics, Inc. \u2013\u2009698004\u201301\/17\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/chara-biologics-inc-698004-01172025"},{"key":"1558_CR26","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Supreme Rejuvenation, LLC\u2009\u2013\u2009700749\u201305\/05\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/supreme-rejuvenation-llc-700749-05052025"},{"key":"1558_CR27","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Platinum Biologics LLC\u2009\u2013\u2009705090\u201308\/15\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/platinum-biologics-llc-705090-08152025"},{"key":"1558_CR28","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Innate Healthcare Institute\u2009\u2013\u2009695592\u201308\/15\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/innate-healthcare-institute-695592-08152025"},{"key":"1558_CR29","unstructured":"Center for biologics evaluation and research. FDA. FDA. 2025. New Life Medical Services, LLC\u2009\u2013\u2009711102\u201309\/24\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/new-life-medical-services-llc-711102-09242025"},{"key":"1558_CR30","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2025. Lux Therapeutics LLC dba Ponya Therapeutics LLC\u2009\u2013\u2009720001\u201311\/25\/2025. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/lux-therapeutics-llc-dba-ponya-therapeutics-llc-720001-11252025"},{"key":"1558_CR31","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2026. Dynamic Stem Cell Therapy\u2009\u2013\u2009712579\u201302\/11\/2026. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/dynamic-stem-cell-therapy-712579-02112026"},{"key":"1558_CR32","unstructured":"Center for Biologics Evaluation and Research. FDA. FDA. 2026. Blue Horizon International, LLC\u2009\u2013\u2009728085\u201305\/26\/2026. Available from: https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/blue-horizon-international-llc-728085-05262026"},{"key":"1558_CR33","unstructured":"Center for biologics evaluation and research. Patient and consumer warning about potential serious risks of harm following use of unapproved products from human cells or tissues. FDA. 2026 May 11. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/patient-and-consumer-warning-about-potential-serious-risks-harm-following-use-unapproved-products"},{"key":"1558_CR34","unstructured":"Center for biologics evaluation and research. Patient and consumer warning about potential serious risks of harm following use of unapproved products from human cells or tissues. FDA. 2026 May 11. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/patient-and-consumer-warning-about-potential-serious-risks-harm-following-use-unapproved-products"},{"key":"1558_CR35","unstructured":"Center for biologics evaluation and research. Public safety notification on exosome products. FDA. 2019 Dec 20. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/public-safety-notification-exosome-products"},{"key":"1558_CR36","unstructured":"Florida house of representatives, health professions & programs Subcommittee. Final bill analysis: CS\/CS\/HB 1617 \u2013 Stem Cell Therapy. Tallahassee (FL): The Florida Senate. 2025 Jun 26. 10 p."},{"key":"1558_CR37","unstructured":"Utah Legislature SB0199 Available from: https:\/\/le.utah.gov\/%7E2024\/bills\/sbillamd\/SB0199.htm"},{"key":"1558_CR38","doi-asserted-by":"publisher","unstructured":"Rikard SM. Chronic Pain Among Adults \u2014 United States, 2019\u20132021. MMWR Morb Mortal Wkly Rep. 2023;72. https:\/\/doi.org\/10.15585\/mmwr.mm7215a1.","DOI":"10.15585\/mmwr.mm7215a1"},{"issue":"5","key":"1558_CR39","doi-asserted-by":"publisher","first-page":"e2313563","DOI":"10.1001\/jamanetworkopen.2023.13563","volume":"6","author":"RL Nahin","year":"2023","unstructured":"Nahin RL, Feinberg T, Kapos FP, Terman GW. Estimated Rates of Incident and Persistent Chronic Pain Among US Adults, 2019\u20132020. JAMA Netw Open. 2023;6(5):e2313563. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.13563.","journal-title":"JAMA Netw Open"},{"key":"1558_CR40","unstructured":"CDC. Overdose Prevention. 2026. Opioid Dispensing Rate Maps. Available from: https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/opioid-dispensing-rate-maps.html"},{"issue":"24","key":"1558_CR41","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMp1904190","volume":"380","author":"D Dowell","year":"2019","unstructured":"Dowell D, Haegerich T, Chou R. No Shortcuts to Safer Opioid Prescribing. N Engl J Med. 2019;380(24):2285\u20137. https:\/\/doi.org\/10.1056\/NEJMp1904190.","journal-title":"N Engl J Med"},{"key":"1558_CR42","doi-asserted-by":"publisher","unstructured":"Dowell D. CDC Clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022. MMWR Recomm Rep. 2022;71. https:\/\/doi.org\/10.15585\/mmwr.rr7103a1.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"1558_CR43","unstructured":"American Medical Association. 2019. How the CDC\u2019s opioid prescribing guidance went astray. Available from: https:\/\/www.ama-assn.org\/public-health\/behavioral-health\/how-cdc-s-opioid-prescribing-guidance-went-astray"},{"key":"1558_CR44","unstructured":"LCD - Epidural Steroid Injections for Pain Management (L39054.). Available from: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?lcdid=39054"},{"key":"1558_CR45","doi-asserted-by":"publisher","first-page":"e079970","DOI":"10.1136\/bmj-2024-079970","volume":"388","author":"JW Busse","year":"2025","unstructured":"Busse JW, Genevay S, Agarwal A, Standaert CJ, Carneiro K, Friedrich J, et al. Commonly used interventional procedures for non-cancer chronic spine pain: a clinical practice guideline. BMJ. 2025;388:e079970. https:\/\/doi.org\/10.1136\/bmj-2024-079970.","journal-title":"BMJ"},{"key":"1558_CR46","unstructured":"LCD - Facet Joint Interventions for Pain Management (L38801.). Available from: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?lcdid=38801"},{"key":"1558_CR47","unstructured":"Moya-Clark A, Medicare Releases Proposed LCD, on Peripheral Nerve Blocks. AAPM. 2025 Oct 15. Available from: https:\/\/painmed.org\/medicare-releases-proposed-lcd-on-peripheral-nerve-blocks\/"},{"issue":"20","key":"1558_CR48","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1001\/jama.2021.19415","volume":"326","author":"KL Bennell","year":"2021","unstructured":"Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, et al. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021;326(20):2021\u201330. https:\/\/doi.org\/10.1001\/jama.2021.19415.","journal-title":"JAMA"},{"issue":"1suppl","key":"1558_CR49","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1177\/1947603520931170","volume":"13","author":"G Filardo","year":"2021","unstructured":"Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage. 2021;13(1suppl):S364\u201375. https:\/\/doi.org\/10.1177\/1947603520931170.","journal-title":"Cartilage"},{"issue":"7","key":"1558_CR50","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.arthro.2023.03.001","volume":"39","author":"JW Belk","year":"2023","unstructured":"Belk JW, Lim JJ, Keeter C, McCulloch PC, Houck DA, McCarty EC, et al. Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2023;39(7):1714\u201334. https:\/\/doi.org\/10.1016\/j.arthro.2023.03.001.","journal-title":"Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc"},{"issue":"1","key":"1558_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12891-021-04308-3","volume":"22","author":"M McLarnon","year":"2021","unstructured":"McLarnon M, Heron N. Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis. BMC Musculoskelet Disord. 2021;22(1):550. https:\/\/doi.org\/10.1186\/s12891-021-04308-3.","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"1558_CR52","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/02692155211011944","volume":"35","author":"XN Xiang","year":"2021","unstructured":"Xiang XN, Deng J, Liu Y, Yu X, Cheng B, He HC. Conservative treatment of partial-thickness rotator cuff tears and tendinopathy with platelet-rich plasma: A systematic review and meta-analysis. Clin Rehabil. 2021;35(12):1661\u201373. https:\/\/doi.org\/10.1177\/02692155211011944.","journal-title":"Clin Rehabil"},{"issue":"9","key":"1558_CR53","doi-asserted-by":"publisher","first-page":"CD010951","DOI":"10.1002\/14651858.CD010951.pub2","volume":"2021","author":"TV Karjalainen","year":"2021","unstructured":"Karjalainen TV, Silagy M, O\u2019Bryan E, Johnston RV, Cyril S, Buchbinder R. Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain. Cochrane Database Syst Rev. 2021;2021(9):CD010951. https:\/\/doi.org\/10.1002\/14651858.CD010951.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1558_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2450\/2022.0087-22","volume":"21","author":"F Masiello","year":"2023","unstructured":"Masiello F, Pati I, Veropalumbo E, Pupella S, Cruciani M, De Angelis V. Ultrasound-guided injection of platelet-rich plasma for tendinopathies: a systematic review and meta-analysis. Blood Transfus Trasfus Sangue. 2023;21(2):119\u201336. https:\/\/doi.org\/10.2450\/2022.0087-22.","journal-title":"Blood Transfus Trasfus Sangue"},{"issue":"6","key":"1558_CR55","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/pm\/pnv053","volume":"17","author":"D Levi","year":"2016","unstructured":"Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E. Intradiscal Platelet-Rich Plasma Injection for Chronic Discogenic Low Back Pain: Preliminary Results from a Prospective Trial. Pain Med. 2016;17(6):1010\u201322. https:\/\/doi.org\/10.1093\/pm\/pnv053.","journal-title":"Pain Med"},{"key":"1558_CR56","doi-asserted-by":"publisher","first-page":"1204144","DOI":"10.3389\/fmed.2023.1204144","volume":"10","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Gong C, Peng X, Liu X, Su X, Tao X, et al. Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Front Med. 2023;10:1204144. https:\/\/doi.org\/10.3389\/fmed.2023.1204144.","journal-title":"Front Med"},{"issue":"3","key":"1558_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1177\/03635465241246524","volume":"53","author":"A Bensa","year":"2025","unstructured":"Bensa A, Previtali D, Sangiorgio A, Boffa A, Salerno M, Filardo G. PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2025;53(3):745\u201354. https:\/\/doi.org\/10.1177\/03635465241246524.","journal-title":"Am J Sports Med"},{"issue":"2","key":"1558_CR58","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/life16020188","volume":"16","author":"FR Costa","year":"2026","unstructured":"Costa FR, Purita J, Martins R, Pires L, Mahmood A, Santos GS, et al. Beyond Platelet Count: Rethinking Platelet-Rich Plasma Efficacy Through Growth Factor Biology and Functional Quality. Life. 2026;16(2):188. https:\/\/doi.org\/10.3390\/life16020188.","journal-title":"Life"},{"key":"1558_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.knee.2021.08.008","volume":"32","author":"U Anil","year":"2021","unstructured":"Anil U, Markus DH, Hurley ET, Manjunath AK, Alaia MJ, Campbell KA, et al. The efficacy of intra-articular injections in the treatment of knee osteoarthritis: A network meta-analysis of randomized controlled trials. Knee. 2021;32:173\u201382. https:\/\/doi.org\/10.1016\/j.knee.2021.08.008.","journal-title":"Knee"},{"issue":"8","key":"1558_CR60","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1177\/03635465211018837","volume":"50","author":"LE Keeling","year":"2022","unstructured":"Keeling LE, Belk JW, Kraeutler MJ, Kallner AC, Lindsay A, McCarty EC, et al. Bone Marrow Aspirate Concentrate for the Treatment of Knee Osteoarthritis: A Systematic Review. Am J Sports Med. 2022;50(8):2315\u201323. https:\/\/doi.org\/10.1177\/03635465211018837.","journal-title":"Am J Sports Med"},{"issue":"12","key":"1558_CR61","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1038\/s41591-023-02632-w","volume":"29","author":"K Mautner","year":"2023","unstructured":"Mautner K, Gottschalk M, Boden SD, Akard A, Bae WC, Black L, et al. Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med. 2023;29(12):3120\u20136. https:\/\/doi.org\/10.1038\/s41591-023-02632-w.","journal-title":"Nat Med"},{"key":"1558_CR62","unstructured":"Center for biologics evaluation and research. Important patient and consumer information about regenerative medicine therapies. FDA. 2024 Apr 8. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/consumers-biologics\/important-patient-and-consumer-information-about-regenerative-medicine-therapies"},{"issue":"2","key":"1558_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/life12020260","volume":"12","author":"RB Timmons","year":"2022","unstructured":"Timmons RB, Sugaya K, Bane LD. Homologous Use of Allogeneic Umbilical Cord Tissue to Reduce Knee Pain and Improve Knee Function. Life. 2022;12(2):260. https:\/\/doi.org\/10.3390\/life12020260.","journal-title":"Life"},{"issue":"42","key":"1558_CR64","doi-asserted-by":"publisher","first-page":"e2406942","DOI":"10.1002\/advs.202406942","volume":"11","author":"Z Li","year":"2024","unstructured":"Li Z, Lu H, Fan L, Ma X, Duan Z, Zhang Y, et al. Microneedle-Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K-Akt-mTOR Pathway. Adv Sci. 2024;11(42):e2406942. https:\/\/doi.org\/10.1002\/advs.202406942.","journal-title":"Adv Sci"},{"issue":"8","key":"1558_CR65","doi-asserted-by":"publisher","first-page":"e13904","DOI":"10.1111\/cts.13904","volume":"17","author":"C Wang","year":"2024","unstructured":"Wang C, Tsai T, Lee C. Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17(8):e13904. https:\/\/doi.org\/10.1111\/cts.13904.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"1558_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12951-024-03088-x","volume":"23","author":"AI Figueroa-Vald\u00e9s","year":"2025","unstructured":"Figueroa-Vald\u00e9s AI, Luz-Crawford P, Herrera-Luna Y, Georges-Calder\u00f3n N, Garc\u00eda C, Tobar HE, et al. Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis. J Nanobiotechnol. 2025;23(1):13. https:\/\/doi.org\/10.1186\/s12951-024-03088-x.","journal-title":"J Nanobiotechnol"},{"key":"1558_CR67","unstructured":"Universidad delos, Andes C. Administration of sEV Derived From UC-MSC in Patients With Osteoarthritis of the Knee: Safety Determination in a Pilot Dose-escalation Study. clinicaltrials.gov; 2024 May. Clinical trial registration no.: NCT06431152. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06431152"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01558-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01558-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01558-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:35:34Z","timestamp":1788503734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01558-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1558"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01558-5","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"26 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain identifying information or images of individual patients.","order":1,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Robinson holds the role Section Editor for Current Pain and Headache Reports.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"118"}}